Welcome to our dedicated page for Masimo news (Ticker: MASI), a resource for investors and traders seeking the latest updates and insights on Masimo stock.
Masimo Corporation (NASDAQ: MASI) is a global medical technology company focused on noninvasive patient monitoring, sensors, patient monitors, and automation and connectivity solutions. The Masimo news feed on Stock Titan aggregates company announcements, financial updates, clinical study results, and other material developments that the company discloses through press releases and regulatory communications.
Investors and observers can find news on Masimo e2 80 99s quarterly and annual financial results, including GAAP and non-GAAP revenue, earnings per diluted share, and constant currency revenue growth, as reported in earnings releases and related Form 8-K filings. These updates often include commentary from management on the performance of the healthcare business, operating efficiency initiatives, and guidance for future periods.
Masimo news also covers strategic and corporate actions, such as the completion of the sale of its consumer audio business, Sound United, to Harman International Industries, Incorporated, as disclosed in a September 23, 2025 Form 8-K and related press release. Additional items may include announcements about investor days, participation in healthcare conferences, and updates on long-range financial targets and growth pillars.
Given Masimo e2 80 99s emphasis on clinical evidence and intellectual property, the news flow features results from clinical and feasibility studies involving Masimo SET ae pulse oximetry, including research on performance across different skin tones and in critically ill patients. It also includes statements on significant legal outcomes, such as jury verdicts in patent infringement cases related to Masimo e2 80 99s technologies. By following this page, readers can monitor how Masimo communicates its financial performance, strategic focus on healthcare monitoring, and developments in clinical validation and intellectual property protection.
Masimo (Nasdaq: MASI) reported strong Q2 2025 financial results, with GAAP revenue reaching $371 million, up 8% year-over-year. The company achieved non-GAAP earnings per diluted share of $1.33, representing a 46% increase from the previous year.
CEO Katie Szyman highlighted the company's successful tariff mitigation efforts, reducing the expected impact by 50%. For 2025, Masimo updated its guidance to include non-GAAP revenue of $1,505-$1,535 million, projecting 8-11% growth. The company revised its non-GAAP EPS guidance to $5.20-$5.45 including tariff impacts, down from $5.45-$5.70 before tariffs.
Masimo (NASDAQ: MASI) has scheduled its second quarter 2025 financial results announcement for Tuesday, August 5, 2025, after market close. The company will host a conference call at 1:30 p.m. PT (4:30 p.m. ET) to discuss the results for the period ended June 28, 2025.
The conference call will be led by CEO Katie Szyman and CFO Micah Young. Participants must register in advance to receive dial-in details and a registrant ID. A replay of the webcast and conference call will be available on Masimo's website after the event.
Masimo (NASDAQ: MASI), a medical technology company specializing in noninvasive monitoring solutions, has joined the American Heart Association Center for Health Technology & Innovation's Innovators' Network. This strategic collaboration provides Masimo access to the Association's digital evidence-based guidelines and clinical recommendations for healthcare technology development.
The Innovators' Network connects entrepreneurs, providers, researchers, and payers, facilitating the development of clinical outcome studies and evidence-based healthcare technologies. Members can leverage the consortium to validate that their digital platforms improve healthcare outcomes, a crucial factor for providers and payers.
Masimo (NASDAQ: MASI) has announced its participation in the upcoming Jefferies Global Healthcare Conference. The company's management will present on Wednesday, June 4, 2025, at 1:25 p.m. Eastern time. Investors and interested parties can access a live webcast of the presentation through Masimo's website. Additionally, a replay of the webcast will be made available after the live presentation.
Masimo (NASDAQ: MASI) has announced its participation in the upcoming BofA Securities 2025 Health Care Conference. The company's management will present on Tuesday, May 13, 2025, at 4:20 p.m. Pacific time. Investors and interested parties can access a live webcast of the presentation through Masimo's website. Additionally, a replay of the webcast will be made available after the live presentation concludes.
Masimo (NASDAQ: MASI) has announced the sale of its Sound United consumer audio business to HARMAN International, a Samsung Electronics subsidiary, for $350 million in cash. The transaction, expected to close by the end of 2025, aligns with Masimo's strategic focus on its core professional healthcare segment.
The deal will integrate Sound United's premium audio brands, including Bowers & Wilkins, Denon, and Marantz, into HARMAN's existing portfolio of JBL, Harman Kardon, and other brands. This strategic move, led by CEO Katie Szyman, aims to streamline Masimo's operations and redirect resources toward addressing unmet clinical needs while driving growth and operational efficiencies.
Masimo (NASDAQ: MASI) has scheduled its first quarter 2025 financial results announcement for Tuesday, May 6, 2025, after market close. The results will cover the period ended March 29, 2025.
The company will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to review the results, led by CEO Katie Szyman and CFO Micah Young. Participants must register online to receive dial-in details and a registrant ID. A replay will be available after the call and archived on Masimo's website.
Masimo (NASDAQ: MASI) has announced its participation in the upcoming 24th Annual Needham Virtual Healthcare Conference. The company's management will present on Wednesday, April 9, 2025 at 2:15 p.m. Eastern time.
A live webcast of the presentation will be accessible through the company's website at www.masimo.com, with a replay option available after the live event.